Table I Index
Table of Contents
Table I - 82 Vanderburgh Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
Number | Rate | Number | Rate | Number | Rate | |
All sites | 813 | 363.1 | 374 | 400.1 | 439 | 347.4 |
Oral cavity and pharynx | 23 | 10.4 | 14 | 14.2** | 9 | 7.3** |
Lip | * | # | * | # | * | # |
Tongue | * | # | * | # | * | # |
Major salivary glands | 5 | 2.3** | * | # | * | # |
Floor of mouth | * | # | * | # | * | # |
Gum and other mouth | * | # | * | # | * | # |
Nasopharynx | * | # | * | # | * | # |
Tonsil | * | # | * | # | * | # |
Oropharynx | * | # | * | # | * | # |
Hypopharynx | * | # | * | # | * | # |
Pharynx and other oral cavity | * | # | * | # | * | # |
Digestive system | 162 | 69.9 | 74 | 78.5 | 88 | 65.0 |
Esophagus | 5 | 2.2** | * | # | * | # |
Stomach | 12 | 5.2** | 7 | 7.7** | 5 | 3.3** |
Small intestine | * | # | * | # | * | # |
Colon excluding rectum | 88 | 36.1 | 42 | 43.5 | 46 | 32.1 |
Rectum and rectosigmoid | 23 | 10.7 | 6 | 6.2** | 17 | 14.5** |
Anus, anal canal, and anorectum | * | # | * | # | * | # |
Liver and intrahepatic bile duct | 10 | 5.0** | 6 | 6.8** | * | # |
Gallbladder | * | # | * | # | * | # |
Other biliary | * | # | * | # | * | # |
Pancreas | 17 | 7.7** | 9 | 10.2** | 8 | 5.7** |
Retroperitoneum | * | # | * | # | * | # |
Peritoneum | * | # | * | # | * | # |
Other digestive organs | * | # | * | # | * | # |
Respiratory system | 157 | 69.4 | 97 | 104.9 | 60 | 44.1 |
Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
Larynx | 12 | 5.0** | 9 | 9.2** | * | # |
Lung and bronchus | 141 | 62.9 | 86 | 93.7 | 55 | 40.3 |
Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
Bones and joints | * | # | * | # | * | # |
Soft tissue (including heart) | 6 | 2.8** | 5 | 5.8** | * | # |
Skin (excluding basal and squamous) | 20 | 9.5 | 12 | 12.6** | 8 | 7.3** |
Melanoma of the skin | 19 | 9.1** | 11 | 11.6** | 8 | 7.3** |
Other non-epithelial skin cancers | * | # | * | # | * | # |
Breast | 137 | 64.2 | * | # | 136 | 114.4 |
Female genital system | 48 | 22.1 | -- | -- | 48 | 39.2 |
Cervix uteri | 6 | 2.9** | -- | -- | 6 | 5.3** |
Corpus uteri | 28 | 12.8 | -- | -- | 28 | 22.8 |
Uterus, NOS | * | # | -- | -- | * | # |
Ovary | 11 | 5.0** | -- | -- | 11 | 8.8** |
Vagina | * | # | -- | -- | * | # |
Vulva | * | # | -- | -- | * | # |
Other female genital organs | * | # | -- | -- | * | # |
Male genital system | 76 | 32.9 | 76 | 80.8 | -- | -- |
Prostate gland | 72 | 30.5 | 72 | 76.0 | -- | -- |
Testis | * | # | * | # | -- | -- |
Penis | * | # | * | # | -- | -- |
Other male genital organs | * | # | * | # | -- | -- |
Urinary system | 59 | 25.0 | 35 | 35.9 | 24 | 18.7 |
Urinary bladder | 35 | 13.3 | 21 | 20.6 | 14 | 8.9** |
Kidney and renal pelvis | 23 | 11.3 | 14 | 15.3** | 9 | 9.2** |
Ureter | * | # | * | # | * | # |
Other urinary organs | * | # | * | # | * | # |
Eye and orbit | * | # | * | # | * | # |
Brain and other nervous system | 17 | 9.3** | 13 | 14.8** | * | # |
Brain | 17 | 9.3** | 13 | 14.8** | * | # |
Other nervous system | * | # | * | # | * | # |
Endocrine system | 6 | 3.0** | * | # | 5 | 4.5** |
Thyroid gland | 5 | 2.4** | * | # | 5 | 4.5** |
Other endocrine (including thymus) | * | # | * | # | * | # |
Lymphoma | 33 | 15.4 | 19 | 21.8** | 14 | 10.1** |
Hodgkin’s disease | * | # | * | # | * | # |
Non-Hodgkin’s lymphoma | 31 | 14.5 | 18 | 20.7** | 13 | 9.2** |
Multiple myeloma | 9 | 3.7** | * | # | 7 | 4.6** |
Leukemia | 24 | 11.1 | 8 | 8.4** | 16 | 14.3** |
Acute lymphocytic | * | # | * | # | * | # |
Chronic lymphocytic | * | # | * | # | * | # |
Acute myeloid | 11 | 5.6** | * | # | 7 | 6.9** |
Chronic myeloid | * | # | * | # | * | # |
Other leukemias | * | # | * | # | * | # |
Other, ill-defined and unknown sites | 30 | 11.8 | 13 | 12.9** | 17 | 11.1** |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |